A consistent biomarker for ICC is expression of Kit. This gene encodes a receptor tyrosine kinase, KIT (aka c-kit), that binds stem cell factor (SCF or KITL). This evidence concerns the gene KITLG and intrahepatic cholangiocarcinoma.